Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability
B Schieffer, E Schieffer, D Hilfiker-Kleiner, A Hilfiker… - Circulation, 2000 - Am Heart Assoc
Background—Patients with an activated renin-angiotensin system (RAS) or genetic alterations
of the RAS are at increased risk of myocardial infarction (MI). Administration of ACE …
of the RAS are at increased risk of myocardial infarction (MI). Administration of ACE …
Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor
MB Marrero, B Schieffer, WG Paxton, L Heerdt, BC Berk… - Nature, 1995 - nature.com
THE peptide angiotensin II is the effector molecule of the renin-angiotensin system. All the
haemodynamic effects of angiotensin II, including vasoconstriction and adrenal aldosterone …
haemodynamic effects of angiotensin II, including vasoconstriction and adrenal aldosterone …
Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor
…, M Stumpf, K Strehlow, A Schmid, B Schieffer… - Circulation …, 2004 - Am Heart Assoc
Angiotensin II type 1 (AT 1 ) receptor activation as well as proinflammatory cytokines such as
interleukin-6 (IL-6) are involved in the development and progression of atherosclerosis. The …
interleukin-6 (IL-6) are involved in the development and progression of atherosclerosis. The …
Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD (P) H oxidase–derived reactive oxygen …
…, E Akin, SM Holland, H Drexler, B Schieffer - Circulation …, 2003 - Am Heart Assoc
Mechanical stretch is a hallmark of arterial hypertension and leads to vessel wall remodeling,
which involves matrix metalloproteinases (MMPs). Because mechanical stretch is further …
which involves matrix metalloproteinases (MMPs). Because mechanical stretch is further …
Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction …
B Schieffer, A Wirger, M Meybrunn, S Seitz, J Holtz… - Circulation, 1994 - Am Heart Assoc
BACKGROUND After myocardial infarction, the noninfarcted left ventricle develops reactive
hypertrophy associated with a depressed coronary flow reserve, myocardial interstitial …
hypertrophy associated with a depressed coronary flow reserve, myocardial interstitial …
Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic …
…, M Fuchs, K Kaminski, A Schaefer, B Schieffer… - Circulation …, 2004 - Am Heart Assoc
The transcription factor signal transducer and activator of transcription 3 (STAT3) participates
in a wide variety of physiological processes and directs seemingly contradictory responses …
in a wide variety of physiological processes and directs seemingly contradictory responses …
Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis
B Schieffer, T Selle, A Hilfiker, D Hilfiker-Kleiner… - Circulation, 2004 - Am Heart Assoc
Background— Vascular lipid accumulation and inflammation are hallmarks of atherosclerosis
and perpetuate atherosclerotic plaque development. Mediators of inflammation, ie, …
and perpetuate atherosclerotic plaque development. Mediators of inflammation, ie, …
How much is too much? Interleukin-6 and its signalling in atherosclerosis
…, C Grothusen, K Grote, B Schieffer - Thrombosis and …, 2009 - thieme-connect.com
The importance of inflammation as a driver of pathology is no longer confined to autoimmune
and infectious diseases. In line with convincing experimental data as well as abundant …
and infectious diseases. In line with convincing experimental data as well as abundant …
Role of NAD (P) H oxidase in angiotensin II–induced JAK/STAT signaling and cytokine induction
B Schieffer, M Luchtefeld, S Braun, A Hilfiker… - Circulation …, 2000 - Am Heart Assoc
Inflammatory processes involve both synthesis of inflammatory cytokines, such as interleukin-6
(IL-6), and the activation of their distinct signaling pathways, eg, the janus kinases (JAKs) …
(IL-6), and the activation of their distinct signaling pathways, eg, the janus kinases (JAKs) …
Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary …
B Schieffer, C Bünte, J Witte, K Hoeper… - Journal of the American …, 2004 - jacc.org
… Bernhard Schieffer… Schieffer and Drexler are recipients of a grant from the Leducq
Foundation. Financial support for this investigator-initiated trial was granted by Sanofi-Synthelabo. …
Foundation. Financial support for this investigator-initiated trial was granted by Sanofi-Synthelabo. …